This site is intended for healthcare professionals.

COVID-19 and nonsteroidal anti-inflammatory drugs

COVID-19 and nonsteroidal anti-inflammatory drugs

Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
2 April 2020
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
David Millar-Jones examines statements from the European Medicines Agency and MHRA regarding the use of ibuprofen in patients with COVID-19.

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

Stay up to date...

Subscribe to our weekly email update with our  latest videos.

Before you go...

Would you like to subscribe to our weekly email update containing links to the latest videos on GPnotebook TV?

Subscribe to our weekly updates.

We also uses anonymous cookies to generate usage statistics. Please click here to find out more.